Bibliography
- Bos JD, Meinardi MM. The 500 Dalton rule for the skin permeation of chemical compounds and drugs. Exp Dermatol 2000;9:165-9
- Kalia YN, Guy RH. Modeling transdermal drug release. Adv Drug Deliv Rev 2000;9:165-9
- Ale I, Lachapelle JM, Maibach HI. Skin tolerability associated with transdermal drug delivery systems: an overview. Adv Ther 2009;26:920-35
- Zuurmond WW, Meert T F, Noorduin H. Partial versus full agonists for opioid-mediated analgesia – focus on fentanyl and buprenorphine. Acta Anaesthesiol Belg 2002;53:193-201
- Griessinger N, Sittl R, Likar R. Transdermal buprenorphine in clinical practice–a post-marketing surveillance study in 13,179 patients. Curr Med Res Opin 2005;21:1147-56
- Bohme K, Likar R. Efficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS), in the treatment of patients with chronic pain. A randomised, double-blind, placebo-controlled study. Pain Clin 2003;15:193-202
- Nitti VW, Sanders S, Staskin DR, Transdermal delivery of drugs for urologic applications: basic principles and applications. Urology 2006;67:657-64
- Bernabei R, Martinez Lage P. Clinical benefits associated with a transdermal patch for dementia. Eur Neurol Rev 2008;3:10-13
- Subedi RK, Oh SY, Chun MK, Choi HK. Recent advances in transdermal drug delivery. Arch Pharm Res 2010;33:339-51
- Padula C, Nicoli S, Aversa V, Bioadhesive film for dermal and transdermal delivery. Eur J Dermatol 2007;17:309-12
- Priano L, Gasco MR, Mauro A. Transdermal treatment options for neurological disorders: impact on the elderly. Drugs Aging 2006;23:357-75
- Murphy M, Carmichael AJ. Transdermal drug delivery systems and skin sensitivity reactions. Incidence and management. Am J Clin Dermatol 2000;1:361-8
- Findling RL, Bukstein OG, Melmed RD, A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2008;69:149-59
- Cartwright R, Cardozo L. Transdermal oxybutynin: sticking to the facts. Eur Urol 2007;51:907-14
- Association of Reproductive Health Physicians. Available from: http://www.arhp.org/publications-and-resources/quick-reference-guide-for-clinicians/DelSys/patch [Last accessed 02 November 2010]
- Ball AM, Smith KM. Optimizing transdermal drug therapy. Am J Health Syst Pharm 2008;65:1337-46
- Wokovich AM, Prodduturi S, Doub WH, Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute. Eur J Pharm Biopharm 2006;64:1-8
- Lee SH, Jeong SK, Ahn SK. An update of the defensive barrier function of skin. Yonsei Med J 2006;47:293-306
- Karch AM. Don't get burnt by the MRI: transdermal patches can be a hazard to patients. Am J Nurs 2004;104:31
- Lachapelle JM, Maibach HI. Patch testing and prick testing: a practical guide. 2nd edition. Berlin Heidelberg, Springer; 2009
- Bircher AJ. Arzneimittelallergie und Haut. Stuttgart, Thieme; 1996
- Mathias CG, Maibach HI. Dermatotoxicology monographs I. Cutaneous irritation: factors influencing the response to irritants. Clin Toxicol 1978;13:333-46
- Levin C, Maibach HI. Transdermal drug delivery system: an overview. In: Zhai H, Wilhelm KP, Maibach HI, editors, Marzulli and Maibach's Dermatotoxicology. 7th edition. CRC Press, Boca Raton, FL; 2008. p. 101-6
- Weltfriend S, Maibach HI. Allergic contact dermatitis. In: Zhai H, Wilhelm KP, Maibach HI, editors, Marzuli and Maibach's Dermatotoxicology. 7th edition. CRC Press, Boca Raton, FL; 2008. p. 125-38
- Marzuli FN, Maibach HI. Allergic contact dermatitis. 2008 In: Zhai H, Wilhelm KP, Maibach HI, editors, Marzuli and Maibach's Dermatotoxicology. 7th edition. CRC Press, Boca Raton, FL; 2008:155-8
- Fadal RG. IgE-mediated hypersensitivity reactions. Otolaryngol Head Neck Surg 1993;109:565-78
- Nieboer C, Bruynzeel DP, Boorsma DM. The effect of occlusion of the skin with transdermal therapeutic system on Langerhans' cells and the induction of skin irritation. Arch Dermatol 1987;123:1499-502
- Lerevre G, Sedek G, Huang HL, Pharmacokinetics of a rivastigmine transdermal patch formulation in healthy volunteers: relative effects of body site application. J Clin Pharmacol 2007;47:471-8
- Kynemund Pedersen L, Agner T, Held E, Johansen JD. Methyldibromoglutaronitrile in leave-on products elicits contact allergy at low concentration. Br J Dermatol 2004;151:817-22
- Eshun K, He Q. Aloe Vera: a valuable ingredient for the food, pharmaceutical and cosmetic industries–a review. Crit Rev Food Sci Nutr 2004;44:91-6
- Hans G, Robert D. Transdermal buprenorphine- a critical appraisal of its role in pain management. J Pain Res 2009;2:117-34
- Kauffman CF, Tompkins PZ, Kauffman WG. Composition, device and method for transdermal delivery of insect repellent. US12175084; 2009
- Atherton P. Aloe Vera revisited. Br J Phytotherapy 1997;4:176-83
- Boudreau MD, Beland FA. An evaluation of the biological and toxicological properties of Aloe Barbadensis (Miller), Aloe Vera. J. Environ. Sci. Health Part C 2006;24:103-54
- Steenkamp V, Stewart MJ. Medicinal applications and toxicological activities of aloe products. Pharm Biol 2007;45:411-20
- Danhof IE. Position statement on polysaccharides. Available from: http://www.gothica.com, 1998 [Last accessed 11 April 2011]
- Femenia A, Sanchez ES, Simal S, Rossello C. Compositional features of polysaccharides from Aloe Vera (Aloe barbadensis Miller) plant tissues. Carbohyd Polym 1999;39:109-17
- Meadows TP. Aloe as a humectant in a new skin preparation. Cosmet Toiletries 1980;95:51-6
- Choi S, Chung M. A review on the relationship between Aloe Vera components and their biologic effects. Sem Integrat Med 2003;1:53-62
- Wichtl M, Bisset NG. Herbal Drugs and Phytopharmaceuticals. Medipharm Scientific Publishers, Stuttgart; 1994. p. 463-9
- Park MK, Park JH, Kim NY, Analysis of 13 phenolic compounds in Aloe species by high performance liquid chromatography. Phytochem Anal 1998;9:186-91
- Saleem R, Faizi S, Deeba F, Anthrones from Aloe barbadensis. Phytochemistry 1997;45:1279-82
- Okamura H, Hine N, Harada S, Diastereomic C-glycosylanthrones of Aloe Vera leaves. Phytochemistry 1997;45:1519-22
- Okamura N, Asaia M, Hinea N, Yagi A. High-performance liquid chromatographic determination of phenolic compounds in Aloe species. J Chromatogr A 1996;746:225-31
- Zonta F, Bogoni P, Masotti P, Micali G. High-performance liquid chromatographic profiles of aloe constituents and determination of aloin in beverages, with reference to the EEC regulation for flavouring substances. J Chromatogr A 1995;718:99-106
- Bruneton J. Pharmacognosy, phytochemistry, medicinal plants. Hampshire, Intercept, England; 1995. p. 434-6
- Chauser-Volfson E, Gutterman Y. The barbaloin content and distribution in Aloe arborescens leaves according to leaf part, age, position and season. Isr J Plant Sci 1996;44:289-96
- Ramachandra CT, Rao PS. Processing of Aloe Vera leaf gel: a review. Am J Agriand Biol Sci 2008;3:502-10
- Moore ED, McAnalley BH. A drink containing mucilaginous polysaccharides and its preparation. US5443830; 1995
- Marshall JM. Aloe Vera gel: what is the evidence? Pharm J 1990;3:360-2
- Dal'Belo SE, Gaspar LR, Campos PM. Moisturizing effect of cosmetic formulations containing Aloe Vera extract in different concentrations assessed by skin bioengineering techniques. Skin Res Technol 2006;12:241-6
- Bouthet CF, Schirf VR, Winters WD. Stimulation of neuron-like cell growth by aloe substances. Phytother Res 1995;9:185-8
- Dunphy JE. Modern biochemical concepts on the healing of wounds: wound healing. Williams and Wilkins, Baltimore, MD; 1974. p. 22-31
- Chithra P, Sajithlal GB, Chandrakasan G. Influence of Aloe Vera on the healing of dermal wounds in diabetic rats. J Ethnopharmacol 1998;59:195-201
- Rodriguez-Bigas M, Cruz NI, Suarez A. Comparative evaluation of Aloe Vera in the management of burn wounds in guinea pigs. Plast Reconstr Surg 1988;81:386-9
- Kaufman T, Kalderon N, Ullmann Y, Berger J. Aloe Vera gel hindered wound healing of experimental second-degree burns: a quantitative controlled study. J Burn Care Rehabil 1988;9:156-9
- Fulton JE. The stimulation of postdermabrasion wound healing with stabilised Aloe Vera gel-polyethylene oxide dressing. J Dermatol Surg Oncol 1990;16:460-7
- Schmidt JM, Greenspoon JS. Aloe Vera dermal wound gel is associated with a delay in wound healing. Obstet Gynecol 1991;1:115-17
- Syed TA, Ahmad SA, Holt AH, Management of psoriasis with Aloe Vera extract in a hydrophilic cream: a placebo-controlled double-blind study. Trop Med Int Health 1996;1:505-9
- Williams MS, Burk M, Loprinzi CL, Phase III double-blind evaluation of an Aloe Vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys 1996;36:345-9
- Heggie S, Bryant GP, Tripcony L, A phase III study on the efficacy of topical Aloe Vera gel on irradiated breast tissue. Cancer Nurs 2002;25:442-51
- Olsen DL, Raub W Jr, Bradley C, The effect of Aloe Vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy. Oncol Nurs Forum 2001;28:543-7
- Vogler BK, Ernst E. Aloe Vera: a systematic review of its clinical effectiveness. Br J Gen Pract 1999;49:823-8